GTBP Institutional Ownership
Top institutional (13F) holders of GTBP and activist (13D/G) positions, sourced from SEC EDGAR.
Institutional owners
11
Institutional value
$406.4M
Top holder
Vanguard Capital Management
Couldn’t find the data you were looking for?
We haven’t added GT Biopharma, Inc.’s filings yet. We add companies and filings all the time.
Track GTBP and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Top holders
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Managementinvestment advisor | Aug 13, 2026 | $184.44M |
| GEODE CAPITAL MANAGEMENT, LLCinvestment advisor | Aug 12, 2026 | $130.65M |
| NORTHERN TRUST CORPinvestment advisor | Aug 13, 2026 | $36.95M |
| CITADEL ADVISORS LLCinvestment advisor | May 15, 2026 | $27M |
| MORGAN STANLEYinvestment advisor | Aug 13, 2026 | $11.05M |
| WELLS FARGO & COMPANY/MNinvestment advisor | Aug 14, 2026 | $7.83M |
| BlackRock, Inc.holding company | Aug 7, 2026 | $4.07M |
| ROYAL BANK OF CANADAinvestment advisor | Aug 14, 2026 | $4M |
| FMR LLCinvestment advisor | May 15, 2026 | $408K |
| UBS Group AGinvestment advisor | Aug 13, 2026 | $1K |
| JPMORGAN CHASE & COinvestment advisor | Aug 12, 2026 | $0 |
Never miss a GTBP filing.
Get an email when GTBP files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR Schedule 13D / 13G and 13F filings.